News Focus
News Focus
icon url

Retiredceo

12/02/19 12:56 PM

#231141 RE: tmac20 #231096

Trac......Research deeper. They were one cent cash flow positive last quarter. At the risk of repeating myself. Sales reps bring in more than they cost or there would be no sales reps. Commercials are advertising. Advertising brings in more money than it costs or no one would advertise.

Simple stuff but if you haven’t been in biz maybe you are unaware of how it works.

Amarin is currently bringing in more money than it needs to pay the costs to do so.
icon url

sts66

12/02/19 4:05 PM

#231186 RE: tmac20 #231096

They missed turning a profit in Q3 because of something like $9M-$10M in stock based compensation. I do expect a wider loss in Q1 based on "ramp up costs" - those 400 new reps and managers will be getting trained and learning their new territories, won't be make many sales at the start - I think JT may have even hinted about wider losses coming, might have been in relation to DTC advertising costs. Q4 is going to get hit hard by stock compensation too, assuming performance goals include gaining FDA approval, which would probably top the list of priorities.